SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-039357
Filing Date
2022-02-14
Accepted
2022-02-14 07:08:56
Documents
14
Period of Report
2022-02-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d312888d8k.htm   iXBRL 8-K 27177
2 EX-99.1 d312888dex991.htm EX-99.1 21474
6 GRAPHIC g312888g0212091306262.jpg GRAPHIC 2968
  Complete submission text file 0001193125-22-039357.txt   178657

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20220212.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20220212_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20220212_pre.xml EX-101.PRE 10809
8 EXTRACTED XBRL INSTANCE DOCUMENT d312888d8k_htm.xml XML 3227
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 22625134
SIC: 2836 Biological Products, (No Diagnostic Substances)